{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:50:03Z","timestamp":1761598203093},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>T cell non-Hodgkin lymphoma (T-NHL) is highly invasive and heterogeneous without accurate prognosis prediction. We proposed peripheral CD16\u2212\/CD16\u2009+\u2009monocytes the additional indicators for T-NHL prognosis. We prospectively recruited 31 T-NHL patients without previous treatment. The CD16\u2212\/CD16\u2009+\u2009monocyte ratio before chemotherapy was calculated and regular follow up was performed to calculate prognostic prediction value. Tumor associated macrophages (TAM) in tumor tissue were counted and transcriptome sequencing of CD16\u2212 and CD16\u2009+\u2009monocytes was applied to explore potential mechanisms. We found that T-NHL patients had higher ratio of total monocytes especially the CD16\u2009+\u2009monocytes along with a decreased ratio of CD16\u2212\/CD16\u2009+\u2009monocytes, compared to the health control. The 1-year overall survival rate was 0.492 and 0.755 for CD16\u2212 monocyte\/CD16\u2009+\u2009monocyte ratio of &lt;11 and \u226511(p\u2009&lt;\u20090.05), respectively. The peripheral CD16\u2212\/CD16\u2009+\u2009monocyte ratio was significantly relevant with the pathological CD68\/CD206 macrophage ratio. The differently expressed genes in CD16\u2212 and CD16\u2009+\u2009monocytes from T-NHL patients were mainly involved in signaling molecules related to tumor microenvironment. Pro-tumor genes were identified in monocyte subsets especially in CD16\u2009+\u2009monocytes. In conclusion, the ratio of peripheral CD16\u2212\/CD16\u2009+\u2009monocyte helps to stratify the prognosis of T-NHL. The relatively increased CD16\u2009+\u2009monocytes may contribute to the pro-tumor microenvironment of T-NHL.<\/jats:p>","DOI":"10.1038\/s41598-020-64579-z","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T10:03:33Z","timestamp":1588932213000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16\u2212\/CD16\u2009+\u2009monocyte ratio"],"prefix":"10.1038","volume":"10","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"64579_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose, J. et al. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26, 4124\u20134130 (2008).","journal-title":"J Clin Oncol"},{"key":"64579_CR2","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1080\/10428190802455867","volume":"49","author":"AN Abouyabis","year":"2008","unstructured":"Abouyabis, A. N. et al. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leukemia & lymphoma 49, 2099\u20132107 (2008).","journal-title":"Leukemia & lymphoma"},{"key":"64579_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11899-010-0062-x","volume":"5","author":"PP Piccaluga","year":"2010","unstructured":"Piccaluga, P. P. et al. Prognostic markers in peripheral T-cell lymphoma. Current hematologic malignancy reports 5, 222\u2013228, https:\/\/doi.org\/10.1007\/s11899-010-0062-x (2010).","journal-title":"Current hematologic malignancy reports"},{"key":"64579_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/10428194.2010.529204","volume":"52","author":"W Zhang","year":"2011","unstructured":"Zhang, W. et al. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified. Leukemia & lymphoma 52, 46\u201352, https:\/\/doi.org\/10.3109\/10428194.2010.529204 (2011).","journal-title":"Leukemia & lymphoma"},{"key":"64579_CR5","doi-asserted-by":"publisher","first-page":"47790","DOI":"10.18632\/oncotarget.17830","volume":"8","author":"X Han","year":"2017","unstructured":"Han, X. et al. Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma. Oncotarget 8, 47790\u201347800, https:\/\/doi.org\/10.18632\/oncotarget.17830 (2017).","journal-title":"Oncotarget"},{"key":"64579_CR6","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock, L. et al. Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74\u201380, https:\/\/doi.org\/10.1182\/blood-2010-02-258558 (2010).","journal-title":"Blood"},{"key":"64579_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2249.2010.04200.x","volume":"161","author":"C Subimerb","year":"2010","unstructured":"Subimerb, C. et al. Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clinical and experimental immunology 161, 471\u2013479, https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04200.x (2010).","journal-title":"Clinical and experimental immunology"},{"key":"64579_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","volume":"18","author":"A Sica","year":"2008","unstructured":"Sica, A. et al. Macrophage polarization in tumour progression. Semin Cancer Biol 18, 349\u2013355, https:\/\/doi.org\/10.1016\/j.semcancer.2008.03.004 (2008).","journal-title":"Semin Cancer Biol"},{"key":"64579_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.imbio.2006.05.025","volume":"211","author":"F Tacke","year":"2006","unstructured":"Tacke, F. & Randolph, G. J. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211, 609\u2013618, https:\/\/doi.org\/10.1016\/j.imbio.2006.05.025 (2006).","journal-title":"Immunobiology"},{"key":"64579_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fimmu.2013.00023","volume":"4","author":"L Ziegler-Heitbrock","year":"2013","unstructured":"Ziegler-Heitbrock, L. & Hofer, T. P. Toward a refined definition of monocyte subsets. Frontiers in immunology 4, 23, https:\/\/doi.org\/10.3389\/fimmu.2013.00023 (2013).","journal-title":"Frontiers in immunology"},{"key":"64579_CR11","doi-asserted-by":"publisher","first-page":"e44450","DOI":"10.1371\/journal.pone.0044450","volume":"7","author":"D Schauer","year":"2012","unstructured":"Schauer, D. et al. Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer. PloS one 7, e44450, https:\/\/doi.org\/10.1371\/journal.pone.0044450 (2012).","journal-title":"PloS one"},{"key":"64579_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/intimm\/13.12.1571","volume":"13","author":"C Sanchez-Torres","year":"2001","unstructured":"Sanchez-Torres, C., Garcia-Romo, G. S., Cornejo-Cortes, M. A., Rivas-Carvalho, A. & Sanchez-Schmitz, G. CD16+ and CD16\u2212 human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells. International immunology 13, 1571\u20131581 (2001).","journal-title":"International immunology"},{"key":"64579_CR13","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1158\/0008-5472.can-16-2310","volume":"77","author":"Z Chen","year":"2017","unstructured":"Chen, Z. et al. Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma. Cancer Res 77, 2266\u20132278, https:\/\/doi.org\/10.1158\/0008-5472.can-16-2310 (2017).","journal-title":"Cancer Res"},{"key":"64579_CR14","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1002\/art.38860","volume":"66","author":"C Burbano","year":"2014","unstructured":"Burbano, C., Vasquez, G. & Rojas, M. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16\u2212 monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus. Arthritis Rheumatol 66, 3371\u20133381, https:\/\/doi.org\/10.1002\/art.38860 (2014).","journal-title":"Arthritis Rheumatol"},{"key":"64579_CR15","first-page":"e328","volume":"5","author":"B Xiu","year":"2015","unstructured":"Xiu, B. et al. IL-10 induces the development of immunosuppressive CD14+HLA-DRlow\/\u2212 monocytes in B-cell non-Hodgkin lymphoma. Blood. Cancer Journal 5, e328 (2015).","journal-title":"Cancer Journal"},{"key":"64579_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cmi.2008.2","volume":"5","author":"JH Lu","year":"2008","unstructured":"Lu, J. H. et al. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol 5, 9\u201321, https:\/\/doi.org\/10.1038\/cmi.2008.2 (2008).","journal-title":"Cell Mol Immunol"},{"key":"64579_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10346","volume":"7","author":"R Bulla","year":"2016","unstructured":"Bulla, R. et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nature communications 7, 10346, https:\/\/doi.org\/10.1038\/ncomms10346 (2016).","journal-title":"Nature communications"},{"key":"64579_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molimm.2016.11.003","volume":"84","author":"B Ghebrehiwet","year":"2017","unstructured":"Ghebrehiwet, B., Hosszu, K. H. & Peerschke, E. I. C1q as an autocrine and paracrine regulator of cellular functions. Molecular immunology 84, 26\u201333, https:\/\/doi.org\/10.1016\/j.molimm.2016.11.003 (2017).","journal-title":"Molecular immunology"},{"key":"64579_CR19","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3892\/mmr.2017.6154","volume":"15","author":"T Wang","year":"2017","unstructured":"Wang, T. et al. Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro. Molecular medicine reports 15, 1172\u20131178, https:\/\/doi.org\/10.3892\/mmr.2017.6154 (2017).","journal-title":"Molecular medicine reports"},{"key":"64579_CR20","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1182\/blood-2017-07-796342","volume":"131","author":"F Vari","year":"2018","unstructured":"Vari, F. et al. Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL. Blood 131, 1809\u20131819, https:\/\/doi.org\/10.1182\/blood-2017-07-796342 (2018).","journal-title":"Blood"},{"key":"64579_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.20082173","volume":"206","author":"DM Kuang","year":"2009","unstructured":"Kuang, D. M. et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 206, 1327\u20131337, https:\/\/doi.org\/10.1084\/jem.20082173 (2009).","journal-title":"J Exp Med"},{"key":"64579_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.placenta.2009.05.001","volume":"30","author":"M Ball","year":"2009","unstructured":"Ball, M. et al. Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis. Placenta 30, 649\u2013653, https:\/\/doi.org\/10.1016\/j.placenta.2009.05.001 (2009).","journal-title":"Placenta"},{"key":"64579_CR23","doi-asserted-by":"publisher","first-page":"e0177964","DOI":"10.1371\/journal.pone.0177964","volume":"12","author":"L Zha","year":"2017","unstructured":"Zha, L. et al. Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis. PloS one 12, e0177964, https:\/\/doi.org\/10.1371\/journal.pone.0177964 (2017).","journal-title":"PloS one"},{"key":"64579_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-258","volume":"9","author":"D Khaitan","year":"2009","unstructured":"Khaitan, D. et al. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC cancer 9, 258, https:\/\/doi.org\/10.1186\/1471-2407-9-258 (2009).","journal-title":"BMC cancer"},{"key":"64579_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1189\/jlb.3MR0117-033R","volume":"102","author":"E Ferretti","year":"2017","unstructured":"Ferretti, E., Corcione, A. & Pistoia, V. The IL-31\/IL-31 receptor axis: general features and role in tumor microenvironment. Journal of leukocyte biology 102, 711\u2013717, https:\/\/doi.org\/10.1189\/jlb.3MR0117-033R (2017).","journal-title":"Journal of leukocyte biology"},{"key":"64579_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2017.05.012","volume":"402","author":"E Castanon","year":"2017","unstructured":"Castanon, E. et al. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. Cancer letters 402, 43\u201351, https:\/\/doi.org\/10.1016\/j.canlet.2017.05.012 (2017).","journal-title":"Cancer letters"},{"key":"64579_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14399","volume":"8","author":"WW Xu","year":"2017","unstructured":"Xu, W. W. et al. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nature communications 8, 14399, https:\/\/doi.org\/10.1038\/ncomms14399 (2017).","journal-title":"Nature communications"},{"key":"64579_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-88","volume":"12","author":"H Kuramochi","year":"2012","unstructured":"Kuramochi, H. et al. Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases. BMC cancer 12, 88, https:\/\/doi.org\/10.1186\/1471-2407-12-88 (2012).","journal-title":"BMC cancer"},{"key":"64579_CR29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1189\/jlb.71.3.511","volume":"71","author":"A Lehtonen","year":"2002","unstructured":"Lehtonen, A., Matikainen, S., Miettinen, M. & Julkunen, I. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte\/macrophage differentiation. Journal of leukocyte biology 71, 511\u2013519 (2002).","journal-title":"Journal of leukocyte biology"},{"key":"64579_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2016.05.005","volume":"378","author":"S Sasaki","year":"2016","unstructured":"Sasaki, S. et al. Essential roles of the interaction between cancer cell-derived chemokine, CCL4, and intra-bone CCR5-expressing fibroblasts in breast cancer bone metastasis. Cancer letters 378, 23\u201332, https:\/\/doi.org\/10.1016\/j.canlet.2016.05.005 (2016).","journal-title":"Cancer letters"},{"key":"64579_CR31","doi-asserted-by":"publisher","first-page":"101042831881005","DOI":"10.1177\/1010428318810059","volume":"40","author":"M De la Fuente Lopez","year":"2018","unstructured":"De la Fuente Lopez, M. et al. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 40, 1010428318810059, https:\/\/doi.org\/10.1177\/1010428318810059 (2018).","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"64579_CR32","doi-asserted-by":"publisher","first-page":"101042831771712","DOI":"10.1177\/1010428317717122","volume":"39","author":"T Cheng","year":"2017","unstructured":"Cheng, T. et al. XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 39, 1010428317717122, https:\/\/doi.org\/10.1177\/1010428317717122 (2017).","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"64579_CR33","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cyto.a.20457","volume":"71","author":"JL Faucher","year":"2007","unstructured":"Faucher, J. L. et al. \u201c6 markers\/5 colors\u201d extended white blood cell differential by flow cytometry. Cytometry Part A 71, 934\u2013944 (2007).","journal-title":"Cytometry Part A"},{"key":"64579_CR34","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"J-FD Paul Blanche","year":"2013","unstructured":"Paul Blanche, J.-F. D. Helene Jacqmin-Gadda Estimating and Comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Statistics in Medicine 32, 5381\u20135397 (2013).","journal-title":"Statistics in Medicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64579-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T10:17:38Z","timestamp":1670321858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64579-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64579"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64579-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7757"}}